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In East Africa, epidemics of Rift Valley fever (RVF) occur in cycles of 5–15 years following
unusually high rainfall. RVF transmission during inter-epidemic periods (IEP) generally
passes undetected in absence of surveillance in mammalian hosts and vectors. We studied
IEP transmission of RVF and evaluated the demographic, behavioural, occupational and
spatial determinants of past RVF infection.
Methodology
Between March and August 2012 we collected blood samples, and administered a risk fac-
tor questionnaire among 606 inhabitants of 6 villages in the seasonally inundated Kilombero
Valley, Tanzania. ELISA tests were used to detect RVFV IgM and IgG antibodies in serum
samples. Risk factors were examined by mixed effects logistic regression.
Findings
RVF virus IgM antibodies, indicating recent RVFV acquisition, were detected in 16 partici-
pants, representing 2.6% overall and in 22.5% of inhibition ELISA positives (n = 71). Four of
16 (25.0%) IgM positives and 11/71 (15.5%) of individuals with inhibition ELISA sero-positivity
reported they had had no previous contact with host animals. Sero-positivity on inhibition
ELISA was 11.7% (95%CI 9.2–14.5) and risk was elevated with age (odds ratio (OR) 1.03 per
year; 95%CI 1.01–1.04), among milkers (OR 2.19; 95%CI 1.23–3.91), and individuals eating
rawmeat (OR 4.17; 95%CI 1.18–14.66). Households keeping livestock had a higher probabil-
ity of having members with evidence of past infection (OR = 3.04, 95%CI = 1.42–6.48) than
those that do not keep livestock.
Conclusion
There is inter-epidemic acquisition of RVFV in Kilombero Valley inhabitants. In the wake of
declining malaria incidence, these findings underscore the need for clinicians to consider
RVF in the differential diagnosis for febrile illnesses. Several types of direct contact with live-
stock are important risk factors for past infection with RVFV in this study’s population.
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However, at least part of RVFV transmission appears to have occurred through bites of
infected mosquitoes.
Author Summary
Rift Valley fever (RVF) is a disease of animals and people that is caused by the RVF virus.
During epidemics, humans get RVF through direct contact with animals or through mos-
quito bites. In East Africa, epidemics occur every 5–15 years following unusually high rain-
fall. In between epidemics, the transmission of RVF might occur at low level. In an
epidemic-free period, we measured whether people in the Kilombero Valley in Tanzania
had evidence of past and recent RVF infection in their blood sample, and studied risk fac-
tors. Three per cent of people had been infected recently, and 12% had evidence of past in-
fection, with increased risk with age, among milkers and among people eating raw meat.
Some people with past or recent infection reported they had not had contact with animals.
Households keeping livestock had more members with evidence of past infection. The find-
ings show that people get infected with RVF in between epidemics, and that various types
of contact with livestock are important risk factors. There is also evidence that some people
get infected with RVFV by mosquitoes in the epidemic free period. Clinicians in the Kilo-
mbero Valley should consider RVF in the differential diagnosis of patients with fever.
Introduction
Rift Valley fever (RVF) is one of the major viral zoonoses in Africa. The disease is caused by
the Rift Valley fever virus (RVFV) of the genus Phlebovirus in the family Bunyaviridae [1], and
it is transmitted to animals through infectious mosquito bites and other arthropod vectors [2].
People become infected either from mosquito bites or by direct or indirect contact with infec-
tious material when exposed to blood, body fluids or tissues of viraemic animals when handling
sick or dead animals as well as through aerosol transmission, consumption of raw milk, meat
or blood [3–5].
The disease was first described in the Rift Valley of Kenya in the early 1900s and the etiolog-
ical agent demonstrated in the early 1930s [6]. RVF epidemics occur in cycles of 5–15 years in
the Eastern Africa region as a result of abnormally high precipitation, for example during the
warm phase of the El Niño/Southern Oscillation (ENSO) phenomenon [7]. In other regions
the disease has been driven by floods caused by other sources including construction of hydro-
electric dams [8]. During the outbreaks the disease causes devastation in livestock populations
and economies of livestock keepers as a result of morbidity, mortality in new-borns and abor-
tions (irrespective of gestation period) with direct negative consequences in the next crop of
new-borns [9].
Public health consequences during epidemics involve a wide range of clinical manifestation
in people including mild illnesses characterized by fever, muscle pain, joint pain, and headache,
which can cause RVF to be confused clinically with other febrile illnesses such as malaria. In
mild cases, symptoms persist for about a week and subside without specific treatment. A small
percentage (0.5–2%) of patients may develop severe forms of the disease characterized by either
ocular disease, meningo-encephalitis or haemorrhagic fever which last for 1–4 weeks after
onset of symptoms [10, 11]. People most at risk include those in close contact with infected an-
imals and infectious materials [4], but also those unprotected from infectious bites of infected
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mosquitoes. Apart from general supportive therapy, there is no established treatment for peo-
ple, and a commercial vaccine for humans is not available either. The control of RVF therefore
relies mainly on vaccination of livestock and preventive measures by humans (including pro-
tection from mosquito bites and avoidance of contact with infected animals and infectious ma-
terial during epidemics). [11].
Inter-epidemic transmission has increasingly been reported in recent years, including in our
study area, but its consequences are not fully understood and its incidence not explored enough
for future epidemic preparedness [8, 12–16]. Relatively little is known regarding the natural
history of RVF as the epidemics occur in remote areas inaccessible during heavy rains; on the
other hand, inter-epidemic RVF transmission presents an opportunity for studying its natural
history as it normally occurs when affected areas are accessible.
In Tanzania, RVF with human involvement has been reported in the past [17, 18], with few
studies demonstrating inter-epidemic transmission in livestock and people [12, 19]. During the
2006/07 RVF epidemic in Tanzania, livestock and people in the Kilombero Valley were affected
[20], and a sero-survey in livestock indicated presence of inter-epidemic period transmission of
RVF [12]. The Kilombero Valley is a seasonally inundated floodplain between the densely forest-
ed escarpment of the Udzungwa mountains to the northwest and the grass covered Mahenge
mountains to the southeast. The annual floods in the valley mimic flooding that may occur else-
where during ENSO years. In the Kilombero Valley, there has been intense malaria transmission
due to abundance of the Anopheles gambiae complex, but other mosquito species including vec-
tors of RVF virus (e.g. Culex spp., Aedes spp. andMansonia spp.) are present [21]. The current
study therefore aimed to 1) determine whether people do acquire RVF during the inter-epidemic
period in the Kilombero Valley and 2) evaluate the demographic, behavioural, occupational, and
spatial determinants of recent and longstanding RVF sero-positivity in people.
Methodology
Study population and area
We conducted the study in rural areas of the Kilombero River Valley, located in the Kilombero
and Ulanga districts in south-eastern Tanzania [22]. The Kilombero Valley is characterized by
seasonal flooding which supports reproduction of large numbers of mosquitoes including arbo-
virus vectors such as Aedes spp [21]. The inhabitants of the two districts engage mainly in
smallholder farming, fishing, and livestock keeping. A serological survey was carried out from
March to August 2012 in six villages, three from each study district, with a total population of
14,517 in 3716 households. About a quarter of households keep livestock [23]. We selected the
villages from hotspots of RVF transmission in the livestock populations in the Kilombero Val-
ley [12]. This aimed at maximizing the probability of detecting inter-epidemic virus activity in
the human population, since the hotspots indicated presence of ecological features that pro-
mote RVF transmission.
Data and sampling
The sample size calculation took into account the fact that sampling was done in households
(clusters), with an average cluster size of 5 individuals per household considered appropriate for
the valley [22] so a design effect of 3 was applied. The design effect adjusted sample size was fur-
ther adjusted for the expected number of covariates we hoped to evaluate, which overall gave a
sample size of 726 in 145 clusters. To ensure equal representation, we selected livestock keepers’
and farmers’ households independently as sampling units, because the two sub-populations are
exposed in different ways to RVF risk factors [24]. In the four villages that were within the
health and demographic surveillance system (IHDSS) of the Ifakara Health Institute, we
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randomly selected farmers’ households from the master list of IHDSS [23]. For farmers’ house-
holds in the other two villages and for livestock keepers’ households in all villages, we obtained
the lists of households from the village office and manually picked every nth household from
the list.
We took blood samples from all members of the household who provided written consent
to participate in the study. For children under 18 years the written consent was provided by pa-
rents or guardians. We collected blood samples into vacutainer tubes containing clot activator
and after clotting, eluted the sera into cryovial tubes and kept these in a car fridge until trans-
ferred to the laboratory. We collected demographic characteristics and individuals’ exposure to
risk factors to RVF through a structured questionnaire.
Serological analyses
We analysed the serum samples for presence of RVFV antibodies by two commercial enzyme-
linked immunosorbent assay (ELISA) kits, an inhibition ELISA and a capture ELISA. The inhibi-
tion ELISA simultaneously detects immunoglobulin G (IgG) and immunoglobulinM (IgM) anti-
bodies against RVFV in humans, domestic and wildlife ruminants (Biological Diagnostic
Supplies Limited, Dreghorn, United Kingdom) [25]. We converted the net optical density (OD)
reading for each sample to a percentage inhibition (PI) value using the equation: [(100 –(net OD
of test sample / mean net OD of negative control) x 100]. Test results producing PI values38.6
are considered positive (following the manufacturer’s recommendations) whereas below that
threshold is negative, with sensitivity and specificity being 99.5% and 99.7% respectively [25]. To
determine recent infection, we then tested the positive samples for the presence of IgM using the
capture IgM ELISA (Biological Diagnostic Supplies Limited, Dreghorn, United Kingdom) [26,
27]. For this test, we used the two intermediate net OD values of positive controls (C+) for the
calculation of the net mean OD value of C+. We then used this value in subsequent calculations
of percentage positivity (PP) of C+, C- and test sera as follows: [PP = (net OD serum/net mean
OD C+) x 100]. The cut off for positive samples’ PP values was7.1, with sensitivity and speci-
ficity being 96.4% and 99.6% respectively [27].
Data analyses
We analysed the data in STATA version 13 (Stata Corp., College Station, Texas, USA). Samples
that were positive by inhibition ELISA were considered to give evidence of past infection in the
individual, as IgG antibodies last long in persons infected in the past [26]. Samples that were
positive by IgM ELISA were considered to indicate recent infection in the individual, as IgM
antibodies are short lived following infection by RVF virus [26, 28]. To examine risk factors of
RVF virus infection and help identify households at higher risk for targeted public health inter-
ventions, we developed three separate mixed effect logistic models. We built two models for in-
dividual level risk factors for recent and past infection as outcome variables respectively and
treated households as a random effect variable. We built a third model for household level fac-
tors with household sero-positivity as outcome variable and villages as random effect variable.
For each model, we first determined the univariable association of individual factors with the
outcome by fitting a logistic regression model. Variables with p-value<0.25 were selected as
potential covariates in the multivariable analysis, where a p-value 0.05 was considered statis-
tically significant. We performed manual forward model-building with subsequent models
evaluated against sparser models by means of the Akaike Information Criterion (AIC). We also
tested two-way interactions between variables included in the model. Lastly, all factors that
were dropped in the process of model building were later tested for any confounding effect. We
considered factors to be a confounder if they led to a change of25% in the coefficient
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estimates. We calculated the population attributable fraction (PAF), a fraction of all cases in
the study population due to exposure to a certain risk factor, as follows: PAF = (Px(RR-1))/
(1+(Px(RR-1))), where Px = estimated population exposure and RR = risk ratio.
Ethics statement
We obtained ethical approval from both the Institutional Review Board of the Ifakara Health
Institute (IHI-IRB) and Medical Research Coordination Committee of the Tanzania’s National
Institute for Medical Research for this study, permit number NIMR/HQ/R.8a/Vol.IX/1101.
Prior to study procedures, participants were explained the study purpose and procedures and
upon agreeing to participate, individual adult participants provided a written informed consent
whereas parents or guardians provided written consent for the under-age participants.
Results
The analyses were based on data from 606 participants in 141 households with complete ques-
tionnaire and laboratory results. We could not attain the a priori calculated sample size because
of consenting issues among household members and because family size was smaller than ex-
pected. We do not anticipate this has introduced underrepresentation of participants with cer-
tain characteristics given the number of clusters involved. Out of 606 participants, 55.6% were
females with age ranging between 2 and 90 years. Fifty four per cent and 46% of the partici-
pants originated from Kilombero and Ulanga districts respectively.
The inhibition ELISA results indicated an overall RVF sero-prevalence of 11.7% (95% CI =
9.2–14.5). There was a linear increase in sero-prevalence in the 10 year cohorts (Fig. 1). Evi-
dence of recent infection by RVFV was found in 16 participants representing 2.6% overall
(n = 606) and 22.5% of inhibition ELISA positive individuals (n = 71). Four of 16 (25.0%) IgM
positives and 11/71 (15.5%) of individuals with inhibition ELISA sero-positivity reported they
had had no previous animal contact, suggesting that at least part of the transmission in the area
occurred through infected mosquito bites.
In the univariable analyses, factors associated with past RVF infection were history of partici-
pating in slaughter of animals (odds ratio [OR] 1.85; 95% CI 1.01–3.42), assisting birthing
Fig 1. Prevalence of Rift Valley fever by age groups. The trend line indicates gradual increase of sero-
positivity with age.
doi:10.1371/journal.pntd.0003536.g001
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animals (OR 2.02; 95% CI 1.12–3.63), milking animals (OR 2.45; 95% CI 1.35–4.45), eating raw
meat/blood (OR 6.01; 95% CI 1.86–19.39), disposing aborted foetus (OR 2.04; 95% CI 1.13–3.67)
and being older (OR 1.03 per year; 95% CI 1.02–1.04) (Table 1). In the multivariable model, age
(OR 1.03; 95% CI 1.01–1.04), milking animals (OR 2.19; 95% CI 1.23–3.91) and eating raw meat/
blood (OR 4.17; 95% CI 1.18–14.66) remained significantly associated with past infection
(Table 2). The PAFs of milking animals and eating raw meat in the past were 29% and 6% re-
spectively. None of the risk factors studied were associated with recent infection (results not
shown).
Though keeping livestock was not associated with individuals’ sero-positivity, households
keeping livestock had a higher chance of having at least one member with past infection
(OR = 3.04, 95% CI = 1.42–6.48) than households that do not keep livestock (table 3). Partici-
pant’s gender, eating meat from dead animals, drinking raw milk, bed net use, proximity to the
main flood area, elevation and district were not associated with inhibition ELISA sero-
positivity.
Discussion
We report here presence of IgM antibodies against RVFV among inhabitants of Kilombero
Valley. This confirms recent infection and thus transmission of RVF which is not linked to the
previous epidemic which happened five years prior in the study area [20]. This finding affirms
our previous report, which highlighted IEP transmission of RVF in livestock [12]. Inter-epi-
demic sero-positivity to RVF in people has also been previously documented in other parts of
Tanzania and Africa [13, 14, 16, 29], with IgM antibodies detected in Nigeria and Chad [14,
29]. The observed sero-prevalence by inhibition ELISA (11.7%) in this study is high compared
to studies from other parts of Tanzania during inter-epidemic period with sero-prevalence of
5.2% and 4% in Mbeya and Tanga regions respectively [13, 19], possibly as a result of our sam-
pling of participants from hotspots of RVF circulation in animals. In Gabon, a country with no
RVF epidemic history, a sero-prevalence of 3.3% has been reported [30], in Kenya, an epidemic
prone country, a mixed picture for inter-epidemic sero-positivity has been recorded in people
in different geographical locality and time [16, 31].
In this study, participants who milked animals were more likely to have evidence of past
RVF infection. This points to a potential public health consequence of RVFV shedding in milk
which occurs during the viraemic phase of the disease. The traditional milking practices create
a lot of aerosols, and if one is milking a viraemic animal the RVFV containing milk particles
could result into infection to milkers through inhalation of the infectious aerosols [32]. Also
skin abrasions on hands of milkers could form an easy route of infection when people have
broken skin. However, drinking raw milk was not associated with longstanding sero-positivity.
Although raw milk consumption is considered an important risk factor during epidemics [18,
33], the infection through oral route comes across barriers including acidic environment in the
stomach [34]. The findings in our study might also be explained by the practice of consuming
fermented milk by the livestock keepers in which case the virus would die when exposed to
acidic environment of sour milk [34].
People who ate raw meat (including blood and internal organs such as kidneys and liver)
were more likely to have evidence of past RVF infection. The animal products (meat and
blood) from infected animals could have a high concentration of RVFV which has the ability to
persist at neutral pH in carcasses. When meat is consumed raw before the pH drops with rigor
mortis this could lead to infection in people. Eating meat from animals that died before slaugh-
ter was not associated with sero-positivity which might be because individuals who reported
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Table 1. Prevalence of RVF inhibition ELISA sero-positivity and association of individual-level variables with sero-positivity.
S/No. Factor Level %Positive (n) OR 95% CI
1 District Kilombero 11.6 (327) 1
Ulanga 11.8 (279) 1.01 0.53–1.79
2 Village Iragua 12.6 (119) 1
Lungongole 10.2 (137) 0.75 0.31–1.84
Lupiro 12.0 (75) 0.91 0.33–2.48
Mofu 15.8 (101) 1.33 0.55–3.21
Nakafuru 10.5 (85) 0.84 0.31–2.25
Sagamaganga 8.9 (89) 0.70 0.25–1.93
3 Sex Female 10.6 (337) 1
Male 13.0 (269) 1.26 0.75–2.12
4 ** Age (year categories) 0–10 1.9 (105) 1
11–20 6.5 (168) 3.59 0.76–16.83
21–30 13.8 (108) 9.02 1.94–41.90
31–40 14.7 (68) 8.95 1.85–43.31
41–50 23.3 (77) 16.97 3.67–78.43
51–60 17.0 (47) 10.87 2.12–55.62
61–70 14.2 (14) 10.24 1.21–86.54
71–80 25.0 (12) 19.71 2.65–146.67
> 80 28.5 (7) 21.43 2.22–206.86
5 Occupation Farmer 11.9 (242) 0.119 0.081–0.167
Livestock keeper 11.7 (356) 0.117 0.086–0.156
Other 0.0 (8) 0.000 0.000–0.369
6 Bed net ownership Yes 11.4 (577) 0.56 0.18–1.73
No 19.2 (26) 1
7 Bed net use Yes 11.0 (532) 0.75 0.34–1.63
No 16.4 (73) 1
8 Keeping livestock Yes 12.0 (365) 1.10 0.61–1.97
No 11.2 (241) 1
9 ** Slaughter animal in the past Yes 17.2 (110) 1.85 1.01–3.42
No 10.5 (493) 1
10 Slaughter a sick animal in the past Yes 16.6 (30) 1.47 0.56–3.88
No 11.5 (562) 1
11 ** Eat raw meat Yes 42.8 (14) 6.01 1.86–19.39
No 10.9 (583) 1
12 * Eat meat from dead animal Yes 14.0 (249) 1.59 0.89–2.85
No 9.8 (314) 1
Don’t know 14.2 (35) 1.50 0.51–4.46
13 ** Milking Yes 16.5 (254) 2.45 1.35–4.45
No 8.2 (350) 1
14 Drink raw milk Yes 12.2 (450) 1.28 0.67–2.43
No 9.8 (152) 1
15 ** Help with birthing animal Yes 17.3 (127) 2.02 1.12–3.63
No 9.6 (458) 1
16 ** Dispose of aborted foetus Yes 18.5 (113) 2.04 1.13–3.67
No 10.1 (464) 1
Signiﬁcance levels at univariable mixed effect logistic regression model,
** < 0.05;
* > 0.05 but < 0.25
doi:10.1371/journal.pntd.0003536.t001
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eating meat from dead animals also reported cooking the meat before consumption, which
would have destroyed the virus.
The high PAF values for milking and for eating raw meat as risk factors present important
educational intervention targets for risk reduction even during epidemic free periods. The in-
creased sero-prevalence in older individuals suggests stable rates of on-going transmission in
the population. The increased sero-prevalence was also evident when participants were catego-
rized into ten-year cohorts, with drops in the 51–60 and 61–70 groups. Older individuals
might have either been infected in one or more previous epidemics or through clinically unde-
tected low-level virus circulation in the study area.
Although there was no significant risk difference between individual livestock keepers and
farmers, households keeping livestock had a higher probability of having at least one member
with past RVF infection. This might imply presence of either higher risk through animal con-
tact as compared to mosquito bites or higher exposure to infectious mosquito bites among live-
stock keepers, as mosquitoes living in close proximity to livestock can pick up infection from
amplifying infected hosts and transmit to livestock keepers even in circumstances of low-level
virus circulation in the general vector populations.
Helping with birthing animals and disposal of aborted foetuses are high risk activities when
dealing with infected animals or infectious materials especially when not wearing proper pro-
tective attire. In this study both were not statistically significant in the final model. People who
reported participating in slaughtering animals in the past (including skinning and butchering)
Table 2. Multivariable analysis of correlates of RVF antibody sero-positivity.
No. Factor Level OR 95% CI
1 Help with birthing animal No 1
Yes 0.83 0.36–1.90
2 Age (years) n/a* 1.03 1.01–1.04
3 Milking No 1
Yes 2.19 1.23–3.91
4 Eat raw meat No 1
Yes 4.17 1.18–14.66
5 Dispose of aborted foetus No 1
Yes 1.35 0.59–3.09
* Age was included as a continuous variable,
OR = odds ratio,
CI = conﬁdence interval
doi:10.1371/journal.pntd.0003536.t002
Table 3. Household-level factors for RVF sero-positivity.
No. Factor Level OR 95% CI
1 Keep livestock No 1
Yes 3.04 1.42–6.48
2 Elevation (meters) n/a* 0.98 0.97–1.00
* Elevation was included as a continuous variable,
OR = odds ratio,
CI = conﬁdence interval
doi:10.1371/journal.pntd.0003536.t003
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were more likely to be sero-positive but the sero-positivity was not associated with slaughtering
sick animals suffering from other unknown conditions. Slaughtering animals sick from RVF
exposes individuals through direct contact with infectious materials such as aerosols from ooz-
ing blood and other organs during skinning and butchering [3].
Although sero-prevalence in male individuals was slightly higher, sex was not associated
with sero-positivity. The sex difference in RVF prevalence has been reported in some studies
[16, 30] but was not apparent in others [13, 19, 35] and where it existed, it has been mostly at-
tributed to gender-biased distribution of animal handling in affected populations. The lack of
association between gender and sero-positivity in this study indicates that either the specific
risk-increasing animal handling activities are equally distributed between genders or that direct
mosquito bites as source of infection to people in the valley was equally important. The latter
possibility is supported in our study area because men were more involved with animal
handling duties.
Bed net ownership and use were not associated with sero-positivity. This is possibly because
in the study area there is high bed net coverage [36], but also because the main RVF vector
Aedesmosquitoes are day biting mosquitoes.
Conclusion
These findings, coupled with our previous report in livestock [12], indicate persistent IEP
transmission of RVFV in both livestock and human populations in the Kilombero Valley. The
animal contact risk factors, especially milking and eating raw meat are important and present
educational intervention targets for risk reduction. In the wake of declining malaria incidence
[37] these findings underscore the need for clinicians to consider RVF in the differential diag-
nosis for febrile illnesses among Kilombero Valley inhabitants. This is relevant regardless of
the person’s occupation, because part of the transmission likely happens through infectious
mosquito bites. The findings also suggest the opportunity and need to further investigate the
circulating RVFV strain as well as the main vectors responsible for IEP transmission.
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